Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9089677
Transcutaneous multimodal delivery system (TMDS)
granted patentUS 9084782
Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
granted patentUS 9084762
T-cell immunogens derived from anti-viral proteins and methods of using same
granted patentUS 9085644
Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
granted patentUS 9080148
Neuronal cells cultured on microparticles and methods of using the neuronal cells
granted patentUS 9078922
Metal-organic frameworks with exceptionally large pore aperatures
granted patentUS 9078881
Salinosporamides and methods of use thereof
granted patentUS 9073980
Tumor selective E1a and E1b mutants
granted patentUS 9072732
Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver di
granted patentUS 9073974
RGD-containing cyclic peptides
granted patentUS 9073884
Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using
granted patentUS 9073863
Cyanoquinoline compounds having activity in correcting mutant-CFTR processing and increasi
granted patentUS 9072792
Peptides whose uptake by cells is controllable
granted patentUS 9066900
Interferon-Ξ² production modulating listeria strains and methods for using same
granted patentUS 9066855
Controlled release auris sensory cell modulator compositions and methods for the treatment
granted patentUS 9061071
Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
granted patentUS 9063125
Compositions comprising cells expressing cold- and menthol-sensitive receptor (CMR1) polyp
granted patentUS 9061048
Cyclic di-AMP induction of type I interferon
granted patentUS 9056924
Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
granted patentUS 9056102
VEGF-activated trail ligands
granted patentUS 9050299
Administration of growth factors for the treatment of CNS disorders
granted patentUS 9050376
Conjugates of synthetic TLR agonists and uses therefor
granted patentUS 9050298
Method of treating ischemia/reperfusion injuries to a heart with netrin-1
granted patentUS 9045752
NKX3-1 saRNA and KLF4 saRNA and uses thereof
granted